PREVALENCE OF FLUOROQUINOLONES RESISTANCE AMONG ESBL-PRODUCING ESCHERICHIA COLI ISOLATED FROM URINE SAMPLES

Authors

  • Ranjan Kumar Sharma Department of Microbiology, Maharishi Markandeshwar Institute of Medical Sciences and Research, Ambala, Haryana, India
  • Nitin Gupta Department of Medicine, Maharishi Markandeshwar Institute of Medical Sciences and Research, Ambala, Haryana, India
  • Gurpreet Banga Department of Microbiology, Maharishi Markandeshwar Institute of Medical Sciences and Research, Ambala, Haryana, India
  • Aditi Minhas Department of Microbiology, Maharishi Markandeshwar Institute of Medical Sciences and Research, Ambala, Haryana, India
  • Rosy Bala Department of Microbiology, Maharishi Markandeshwar Institute of Medical Sciences and Research, Ambala, Haryana, India
  • Harit Kumar Department of Microbiology, Maharishi Markandeshwar Institute of Medical Sciences and Research, Ambala, Haryana, India

DOI:

https://doi.org/10.22159/ajpcr.2024.v17i4.50968

Keywords:

Extended-spectrum beta-lactamase, anti-microbial resistance, Fluoroquinolone resistance

Abstract

Objectives: Resistance among uropathogens has emerged as a growing concern necessitating re-evaluation of the efficacy of recommended empiric antimicrobial regimens. Misuse and overuse of various antibacterial agents in hospitals are a key cause of the emergence of anti-microbial resistance.

The study aimed to identify the prevalence of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli from urine specimens and to know the prevalence of Fluoroquinolone resistance among ESBL-producing E. coli isolates.

 Methods: The study was conducted on 500 E. coli isolates from urine samples received in the Department of Microbiology, MMIMSR, Mullana, Ambala. The organism isolation and identification were done as per the standard procedures and antibiotic sensitivity testing was done following Clinical Laboratory Standard Institute (CLSI) guidelines. All the strains were screened out for ESBL production as per CLSI guidelines. Ciprofloxacin, Norfloxacin, and Ofloxacin discs were used for the detection of fluoroquinolone resistance.

Results: Out of the total 500 E. Coli isolates from urine samples received in our laboratory, 69% were found to be ESBL producers.

Conclusion: We found a high level of quinolone resistance among ESBL-producing E. coli strains isolated from patients with urinary tract infections. Because of the widespread use of fluoroquinolones in our country, there is a need for sensitive antibiotic stewardship. Further research is needed to ascertain the gravity of quinolone resistance and to swiftly act against its spread among other nosocomial pathogens.

Downloads

Download data is not yet available.

References

Magale HI, Kassim IA, Odera SA, Omolo MJ, Jaoko WG, Jolly PE. Antibiotic susceptibility of organisms causing urinary tract infection in patients presenting at Kenyatta National Hospital, Nairobi. East Afr Med J. 2015 Jul;92(7):333-37. PMID 27867208

Medina M, Castillo-Pino E. An introduction to the epidemiology and burden of urinary tract infections. Ther Adv Urol. 2019 May 2;11:AQ4 1756287219832172. doi: 10.1177/1756287219832172, PMID 31105774

Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: A clinical update. Clin Microbiol Rev. 2005 Oct;18(4):657-86. doi: 10.1128/CMR.18.4.657-686.2005, PMID 16223952

Chokshi A, Sifri Z, Cennimo D, Horng H. Global contributors to antibiotic resistance. J Glob Infect Dis. 2019;11(1):36-42. doi: 10.4103/ jgid.jgid_110_18, PMID 30814834

Pitout JD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J Antimicrob Chemother. 2005;56(1, Jul):52-9. doi: 10.1093/jac/dki166, PMID 15917288

Robicsek A, Jacoby GA, Hooper DC. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis. 2006;6(10):629-40. doi: 10.1016/S1473-3099(06)70599-0, PMID 17008172

Yamane K, Wachino J, Suzuki S, Kimura K, Shibata N, Kato H, et al. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob Agents Chemother. 2007 Sep;51(9):3354-60. doi: 10.1128/AAC.00339-07, PMID 17548499

Colee JG, Fraser AG, Marmion BP, Simmons A. Test for identification of bacteria. In: Mackie & McCartney Practical Medical Microbiology. 14th ed. United Kingdom: Churchill Livingstone; 1996. p. 131-50.

Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fourth Informational Supplement. M100-S24. Wayne, PA: Clinical and Laboratory Standards Institute; 2020.

Khodare A, Mutha A, Purohit M. Prevalence of extended-spectrum β-lactamases producing Escherichia coli in urinary specimens and their phenotypic detection by modified three-dimensional enzyme extract tesh: Comparison with the phenotypic confirmatory disc diffusion test. Indian J Microbiol Res. 2017;4(3):244-47.

FarajzadehSheikh A, Veisi H, Shahin M, Getso M, Farahani A. Frequency of quinolone resistance genes among extended-spectrum β-lactamase (ESBL)-producing Escherichia coli strains isolated from urinary tract infections. Trop Med Health. 2019 Mar 4;47:19. doi: 10.1186/s41182-019-0147-8, PMID 30872947

Abduzaimovic A, Aljicevic M, Rebic V, Vranic SM, Abduzaimovic K, Sestic S. Antibiotic resistance in urinary isolates of Escherichia coli. Mater Sociomed. 2016 Dec;28(6):416-19. doi: 10.5455/ msm.2016.28.416-419, PMID 28144190

Moue A, Syed AQ, Aktaruzzaman, Ferdous N, Karim R, Khalil MM, Das AK. Prevalence of urinary tract infection in both outpatient department and in patient department at a medical college setting of Bangladesh. Int J Biosci. 2015;7(5):146-52.

Jia P, Zhu Y, Li X, Kudinha T, Yang Y, Zhang G, et al. High prevalence of extended-spectrum beta-lactamases in Escherichia coli strains collected from strictly defined community-acquired urinary tract infections in adults in China: A multicenter prospective clinical microbiological and molecular study. Front Microbiol. 2021 Jul 7;12:663033. doi: 10.3389/ fmicb.2021.663033, PMID 34305831

Cebeci T, Keskin D. Antimicrobial susceptibility profiles and prevalence of ESBLS among Escherichia coli isolates recovered from clinical specimens in different services, middle Black Sea. J Health Sci. 2019;5(3):186-91.

Noor AF, Shams F, Munshi SK, Hassan M, Noor R. Prevalence and antibiogram profile of uropathogens isolated from Hospital and community patients with urinary tract infections in Dhaka city. J Bangladesh Acad Sci. 2013;37(1):57-63. doi: 10.3329/jbas. v37i1.15681

Madani H, Khazaee S, Kanani M, Shahi M. Antibiotic resistance pattern of E. coli isolated from urine culture in imam Reza Hospital Kermanshah-2006. J Kermanshah Univ Med Sci. 2008;12(3):e79965.

Nimri L, Azaizeh B. First report of multidrug-resistant ESBL-producing urinary Escherichia coli in Jordan. Br Microbiol Res. 2012;J2(2):71-81.

Park JH, Lee SH. Characterization and prevalence of Escherichia coli and Klebsiella pneumoniae isolates producing an extended-spectrum -Lactamase from Korean hospitals. Korean J Lab Med. 2003;23:18-24.

Pakzad I, Ghafourian S, Taherikalani M, Sadeghifard N, Abtahi H, Rahbar M, et al. qnr Prevalence in extended spectrum beta-lactamases (ESBLs) and None-ESBLs Producing Escherichia coli isolated from urinary tract infections in central of Iran. Iran J Basic Med Sci. 2011 Sep;14(5):458-64. PMID 23493061

Tayebi Z, Heidari H, Kazemian H, Ghafoori SM, Boroumandi S, Houri H. Comparison of quinolone and beta-lactam resistance among Escherichia coli strains isolated from urinary tract infections. Infez Med. 2016 Dec 1;24(4):326-30. PMID 28011969

Singh RM, Singh HL. Comparative evaluation of six phenotypic methods for detecting extended-spectrum beta-lactamase-producing Enterobacteriaceae. J Infect Dev Ctries. 2014 Apr 15;8(4):408-15. doi: 10.3855/jidc.4052, PMID 24727505

Hassan SA, Jamal SA. Occurrence of multidrug resistant and ESBL producing E. coli causing urinary tract infections. J Basic Appl Sci. 2011;7(1):39-43.

Ahmed I, Sajed M, Sultan A, Murtaza I, Yousaf S, Maqsood B, et al. The erratic antibiotic susceptibility patterns of bacterial pathogens causing urinary tract infections. EXCLI J. 2015;14:916-25. doi: 10.17179/ excli2015-207, PMID 26648826

Jamil J, Haroon M, Sultan A, Khan MA, Gul N, Kalsoom. Prevalence, antibiotic sensitivity and phenotypic screening of ESBL/MBL producer E. coli strains isolated from urine; District Swabi, KP, Pakistan. J Pak Med Assoc. 2018 Nov;68(11):1704-07. PMID 30410154

Published

07-04-2024

How to Cite

Ranjan Kumar Sharma, Nitin Gupta, Gurpreet Banga, Aditi Minhas, Rosy Bala, and Harit Kumar. “PREVALENCE OF FLUOROQUINOLONES RESISTANCE AMONG ESBL-PRODUCING ESCHERICHIA COLI ISOLATED FROM URINE SAMPLES”. Asian Journal of Pharmaceutical and Clinical Research, vol. 17, no. 4, Apr. 2024, pp. 14-16, doi:10.22159/ajpcr.2024.v17i4.50968.

Issue

Section

Original Article(s)